Scientist at the Department of Chemistry
My research focuses on mass spectrometry–based clinical metabolomics, with particular emphasis on metabolic processes underlying brain tumor development. Central objectives include metabolic phenotyping of tumor subtypes and the identification of metabolic markers for early detection, progression assessment, and treatment monitoring. This work is driven by strong national and international collaborations with clinical researchers.